These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

816 related articles for article (PubMed ID: 15728813)

  • 1. Chronic lymphocytic leukemia.
    Chiorazzi N; Rai KR; Ferrarini M
    N Engl J Med; 2005 Feb; 352(8):804-15. PubMed ID: 15728813
    [No Abstract]   [Full Text] [Related]  

  • 2. [Repertory of T lymphocytes in patients with stage A chronic lymphoid leukemia: revealed by monoclonal expansion of T cells in vivo].
    Farace F; Kremer F; Dietrich PY; Gaudin C; Angevin E; Courtier MH; Bayle C; Hercend T; Triebel F
    Bull Cancer; 1994 Oct; 81(10):897-9. PubMed ID: 7734775
    [No Abstract]   [Full Text] [Related]  

  • 3. Evidence for distinct pathomechanisms in genetic subgroups of chronic lymphocytic leukemia revealed by quantitative expression analysis of cell cycle, activation, and apoptosis-associated genes.
    Kienle DL; Korz C; Hosch B; Benner A; Mertens D; Habermann A; Kröber A; Jäger U; Lichter P; Döhner H; Stilgenbauer S
    J Clin Oncol; 2005 Jun; 23(16):3780-92. PubMed ID: 15867199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perspectives in chronic lymphocytic leukemia biology and management.
    Dighiero G
    Hematol Oncol Clin North Am; 2004 Aug; 18(4):927-43, x. PubMed ID: 15325707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation antigens and signal transduction in lymphocyte activation.
    Immunol Rev; 1987 Feb; 95():1-194. PubMed ID: 3494662
    [No Abstract]   [Full Text] [Related]  

  • 6. B-cell receptor translocation to lipid rafts and associated signaling differ between prognostically important subgroups of chronic lymphocytic leukemia.
    Allsup DJ; Kamiguti AS; Lin K; Sherrington PD; Matrai Z; Slupsky JR; Cawley JC; Zuzel M
    Cancer Res; 2005 Aug; 65(16):7328-37. PubMed ID: 16103084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chronic lymphoid leukemia. Diagnosis, course, prognosis, principles of treatment].
    Chèze S; Leporrier M
    Rev Prat; 1999 Mar; 49(5):539-46. PubMed ID: 10358405
    [No Abstract]   [Full Text] [Related]  

  • 8. [Chronic lymphocytic leukemia. II. Differentiation of various forms of chronic lymphocytic leukemia by cytological and immunological indicators].
    Popova L; Apostolov P; Vlaĭkova S; Stamenova L
    Vutr Boles; 1988; 27(3):76-80. PubMed ID: 3264645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunologic phenotype of lymphocytes in chronic B-cell lymphocytic leukemia. I. B- and T-lymphocytes in chronic lymphocytic leukemia].
    Rupniewska ZM; Wach M; Kowal M; Roliński J; Antosz H
    Acta Haematol Pol; 1992; 23(1):21-7. PubMed ID: 1615748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface immunoglobulin-mediated signal transduction involves rapid phosphorylation and activation of the protooncogene product Raf-1 in human B-cells.
    Tamaki T; Kanakura Y; Kuriu A; Ikeda H; Mitsui H; Yagura H; Matsumura I; Druker B; Griffin JD; Kanayama Y
    Cancer Res; 1992 Feb; 52(3):566-70. PubMed ID: 1732044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine- and immune-based therapy in chronic lymphocytic leukemia.
    Le Dieu R; Gribben J
    Semin Oncol; 2006 Apr; 33(2):220-9. PubMed ID: 16616069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting Progression--ZAP-70 in CLL.
    Hamblin TJ
    N Engl J Med; 2004 Aug; 351(9):856-7. PubMed ID: 15329421
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical staging and prognostic markers in chronic lymphocytic leukemia.
    Rai KR; Wasil T; Iqbal U; Driscoll N; Patel D; Janson D; Mehrotra B
    Hematol Oncol Clin North Am; 2004 Aug; 18(4):795-805, vii. PubMed ID: 15325699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolymphocytic transformation of a low-grade lymphocytic neoplasia: chronic lymphocytic leukemia/lymphoma [corrected].
    Shahidi-Asl M; Aydin F; Beltran GS
    J La State Med Soc; 1998 May; 150(5):226-31. PubMed ID: 9642926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Functional properties of B-lymphocytes of patients with a B-cell variant of chronic lymphocytic leukemia and chronic glomerulonephritis].
    Ostanin AA; Chernykh ER; Shubinskiĭ GZ; Nekipelova VI; Tov NL; Lozovoĭ VP
    Vestn Akad Med Nauk SSSR; 1991; (12):19-23. PubMed ID: 1801468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiologic mechanisms of chronic lymphocytic leukemia and their application to therapy.
    Rai KR
    Exp Hematol; 2007 Apr; 35(4 Suppl 1):134-6. PubMed ID: 17379098
    [No Abstract]   [Full Text] [Related]  

  • 17. Late induction of CREB/ATF binding and a concomitant increase in cAMP levels in T and B lymphocytes stimulated via the antigen receptor.
    Feuerstein N; Firestein R; Aiyar N; He X; Murasko D; Cristofalo V
    J Immunol; 1996 Jun; 156(12):4582-93. PubMed ID: 8648100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface markers of lymphocytes and immunoglobulin alterations in chronic lymphocytic leukemia (CLL).
    Aydar S; Oğüt A; Undük H; Gündüz M
    New Istanbul Contrib Clin Sci; 1978 Mar; 12(2):152-60. PubMed ID: 16302701
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of T cells on B cell colony formation in patients with B-chronic lymphocytic leukemia].
    Abe S; Ishiyama T; Wakabayashi Y
    Rinsho Ketsueki; 1988 Jul; 29(7):1036-40. PubMed ID: 3263518
    [No Abstract]   [Full Text] [Related]  

  • 20. Monoclonal B-cell lymphocytosis--a frequent premalignant condition.
    Dighiero G
    N Engl J Med; 2008 Aug; 359(6):638-40. PubMed ID: 18687646
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 41.